Jerry Ting W.

Jerry Ting W. is an accomplished professional with extensive experience in the fields of health product development and molecular diagnostics. Currently serving as the Owner of Innovative Formulation LLC since March 2023 and as an Associate Scientist at Invivoscribe since September 2022, Jerry leads projects focused on flavor optimization and the commercialization of molecular diagnostic assays targeting the IVDR market. As the Owner of NXLVL since September 2021, Jerry's mission involves leveraging multidisciplinary expertise to develop innovative health products, addressing gaps in functional health ingredients. With a strong background in assay development accumulated during tenures at Genoptix, Inc. and Sequenom Center for Molecular Medicine, among others, Jerry has a proven track record in product design, optimization, and commercialization in both laboratory and market settings. Educational credentials include a degree in Pharmacological Chemistry and Biochemistry from UC San Diego.